Detalhe da pesquisa
1.
Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys.
J Pharmacol Exp Ther
; 384(1): 155-162, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36272734
2.
Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys.
J Pharmacol Exp Ther
; 382(2): 181-187, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643857
3.
OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects.
Behav Pharmacol
; 33(6): 377-394, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947066
4.
Interactions between impulsivity and MDPV self-administration in rats.
Addict Biol
; 27(3): e13168, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470552
5.
OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention.
J Pharmacol Exp Ther
; 372(2): 205-215, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31748404
6.
Impact of order of fixed-ratio presentation on demand for self-administered remifentanil in male rats.
Behav Pharmacol
; 31(2&3): 216-220, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31577559
7.
Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors.
Handb Exp Pharmacol
; 258: 127-145, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451969
8.
Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys.
J Pharmacol Exp Ther
; 368(1): 88-99, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30401680
9.
Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel µ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys.
J Pharmacol Exp Ther
; 368(2): 229-236, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30463875
10.
Effects of daily morphine treatment on impulsivity in rats responding under an adjusting stop-signal reaction time task.
Behav Pharmacol
; 29(8): 676-687, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29595542
11.
Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.
Behav Pharmacol
; 27(2-3 Spec Issue): 249-57, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397756
12.
Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats.
Behav Pharmacol
; 27(1): 69-72, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26292184
13.
Delay discounting of the µ-opioid receptor agonist remifentanil in rhesus monkeys.
Behav Pharmacol
; 27(2-3 Spec Issue): 148-54, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397761
14.
Effect of daily morphine administration and its discontinuation on delay discounting of food in rhesus monkeys.
Behav Pharmacol
; 27(2-3 Spec Issue): 155-64, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397762
15.
Impact of efficacy at the µ-opioid receptor on antinociceptive effects of combinations of µ-opioid receptor agonists and cannabinoid receptor agonists.
J Pharmacol Exp Ther
; 351(2): 383-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25194020
16.
Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice.
Pharmacol Biochem Behav
; 234: 173673, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951365
17.
Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders.
Psychopharmacology (Berl)
; 241(7): 1477-1490, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710856
18.
Effect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeys.
J Pharmacol Exp Ther
; 347(3): 557-63, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24042159
19.
Interactions between µ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.
J Pharmacol Exp Ther
; 345(3): 354-62, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23536317
20.
Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder.
J Exp Anal Behav
; 119(2): 392-406, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759567